Key Kratom Questions and Answers Kratom has been the subject of controversy in recent years, with conflicting opinions about its safety, legality, and efficacy. As a result, many people are left with unanswered questions about this plant and its potential benefits or risks. To shed light on this topic, check out this article where you can find the compilation of the key questions and answers about kratom. https://kratomlords.com/kratom-research/key-kratom-questions-and-answers/ #people #safety #kratom #kratomlegality #banned #risks #kratomresearch #research #kratomstudy

G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder Background and Purpose Mitragyna speciosa, more commonly known as kratom, is a plant that contains opioidergic alkaloids but is unregulated in most countries. Kratom is used in the self-medication and may be less dangerous than typical opioids because of the stronger preference of kratom alkaloids to induce receptor interaction with G proteins over β-arrestin proteins. The study hypothesizes that kratom (alkaloids) can also reduce alcohol intake. #science #research #kratomresearch #kratomstudy #alkaloids #proteins https://kratomlords.com/kratom-research/protein-biased-kratom-alkaloids-potential-treatments/

atai Life Sciences - Phase 1 trial of kratom-derived pharmaceutical atai and Kures are poised to address two key factors underlying the opioid epidemic developing a potentially safer and more widely available alternative for both pain management and opioid maintenance therapy. One of the leading therapeutic indicators of kratom is its analgesic effect. One study of Kratom users in Malaysia showed that 90% were using kratom as a substitute for opioids, with 84% reporting that kratom eased their opioid withdrawal symptoms. #7hydroxymitragynine #atai #kratom #KratomEffects #opioids #alternative #KratomResearch #KratomStudy #kratomtrial #mitragynaspeciosa #pharmaceutical #WhatisKratom https://kratomlords.com/kratom-research/atai-life-sciences-phase-1-trial-kratom-derived-pharmaceutical/